Background Public involvement in clinical trials has developed rapidly and is now expected by funders, research ethics committees, researchers and members of the public. Despite benefitting the research, researchers and public members involved, public involvement can be challenging and tokenistic. For several years, a cancer clinical trials unit (CTU) in Wales, in association with a government ...
